Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

Desmopressin (DDAVP), a synthetic peptide analog of vasopressin, is a safe antidiuretic and hemostatic compound that acts as a selective agonist for the vasopressin V2 membrane receptor. It is known that DDAVP can inhibit progression of residual metastatic cells and also improves chemotherapy effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Ripoll, Giselle V., Garona, Juan, Pifano, Marina, Farina, Hernan G., Gomez, Daniel E., Alonso, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825504/
https://www.ncbi.nlm.nih.gov/pubmed/24122393
http://dx.doi.org/10.1007/s10549-013-2724-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825504/
https://www.ncbi.nlm.nih.gov/pubmed/24122393
http://dx.doi.org/10.1007/s10549-013-2724-6

Ejemplares similares